CCIA
IRON icon

Campbell & Co Investment Adviser’s Disc Medicine IRON Stock Holding History

Campbell & Co Investment Adviser’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
+25,568
New +$1.76M 0.1% 342
2026
Q1 		– Sell
-17,399
Closed -$1.38M – 1231
2025
Q4 		$1.38M Buy
17,399
+12,109
+229% +$1.02M 0.07% 445
2025
Q3 		$350K Buy
+5,290
New +$315K 0.03% 856

Other funds holding IRON

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
IGAM
iA Global Asset Management Quebec, Quebec, Canada $8.42B AUM 47.61% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Campbell & Co Investment Adviser's IRON Position: Q2 2026 in Review

Campbell & Co Investment Adviser opened a new position in Disc Medicine (IRON) in Q2 2026: 25,568 shares worth $1.87M. The stake represents 0.1% of the portfolio and ranks #342 among its holdings. This is a return to the name: Campbell & Co Investment Adviser previously reported a position in IRON as recently as Q4 2025.

Campbell & Co Investment Adviser first reported a position in IRON in Q3 2025 and has held it in 3 quarters since. 38 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Campbell & Co Investment Adviser held 25,568 shares of Disc Medicine worth $1.87M as of Q2 2026.
  • Disc Medicine was a new Campbell & Co Investment Adviser position in Q2 2026.
  • Disc Medicine made up 0.1% of Campbell & Co Investment Adviser's portfolio in Q2 2026, its #342 holding.
  • Campbell & Co Investment Adviser first reported a position in Disc Medicine in Q3 2025 and has held it in 3 quarters since.
  • 38 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2026, filed 3 Aug 2026.